PCMA SmartBrief

Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejlSCfbwocfasBalwIsQ

February 5, 2013

Forward

Archive

News for the PBM Industry

Featured Story

Pharmacy boards have no business regulating PBMs, compounders
Some state pharmacy boards have moved away from their main job of overseeing pharmacists and now claim new authority to regulate pharmacy benefit managers and drug compounders, a recent Bloomberg BNA article said. Pharmacists who sit on state pharmacy boards face a conflict of interest in overseeing entities whose success or failure affects board members' own incomes. RxObserver blog (2/4)

Legislative & Regulatory News

Biosimilars, CMOs on FDA's list for guidelines coming this year
The FDA unveiled a list of coming guidance documents that include the expected release this year of guidelines for biosimilars and quality agreements for contract manufacturing organizations. In-PharmaTechnologist.com (2/4)

Help wanted: Health insurance marketplace "navigators"
States will have to hire thousands of people to help consumers navigate health insurance marketplaces, incurring significant cost and logistical challenges, experts say. The Washington Post (2/4)

HHS secretary reassures states on Medicaid expansion
Saying that Medicaid expansion under the Affordable Care Act is not a "bait and switch," HHS Secretary Kathleen Sebelius sought to reassure states that funding for the expansion will not fall victim to budget negotiations. Politico (Washington, D.C.) (2/5)

Ohio's Kasich backs expanding Medicaid for jobless, working poor
Ohio Gov. John Kasich endorsed Medicaid expansion under the Affordable Care Act in his budget proposal, making him the fifth Republican governor to back the plan. "Gov. Kasich's decision will not only help hundreds of thousands of Buckeyes, but it will also help to break the logjam among Republican governors," said Ron Pollack of the advocacy group Families USA. The Washington Times/The Associated Press (2/4), Reuters (2/4), The Huffington Post (2/5)

Drug Industry Spotlight

Sun Pharma gets FDA nod for generic Doxil
Sun Pharma received FDA approval for its generic version of Johnson & Johnson's cancer drug Doxil. The approval may help address a severe shortage of the medication. Reuters (2/4)

SmartQuote

Failure changes for the better, success for the worse."

--Seneca the Younger,
Roman philosopher, statesman and playwright

Subscriber Tools

Print friendly format | Web version | Search past news | Archive | Privacy policy

Contact PCMA

Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Follow PCMA on Twitter

About PCMA

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.


	Recent PCMA SmartBrief Issues: Monday, February 04, 2013 Friday, February 01, 2013 Thursday, January 31, 2013 Wednesday, January 30, 2013 Tuesday, January 29, 2013			Lead Editor: Melissa Turner Mailing Address: SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004